Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT02309658
Eligibility Criteria:
Inclusion Criteria:
* Histological confirmed diagnostic of cervical carcinoma
* International Federation of Gynecology and Obstetrics (FIGO) stage Ib2 (\>4cm) to IVa
* Performance status 0-2 (ECOG scale)
* Hemoglobin \>10g/dl , neutrophil \> 1500 /mm3, platelet \>100.000/mm3
* Creatinine \< 1,5 mg/dl
* Bilirubin total \<1,6 mg/dl and liver enzymes (AST e ALT) \< 2x (upper limit of normal)
* Informed consent.
Exclusion Criteria:
* Cervical tumors with adenocarcinoma, adenosquamous and small cell adenocarcinoma histology
* Distant metastasis including paraortic nodes
* Pregnancy and breast-feeding
* Previous chemotherapy, radiotherapy or uterine surgery
* Relevant co-morbidity which prevent chemotherapy use
* Previous neoplasia, except non-melanoma skin cancer
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02309658
Study Brief:
Protocol Section:
NCT02309658